Inventor · disambiguated record
Flavia Chiuppesi
Also filed as: CHIUPPESI FLAVIA
2 granted patents·6 pending applications·0 citations·filing 2018–2022
25Inventor score
Top patents by PatentIndex Score
8 records- 0161US11384137B2MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereofHOPE CITY·Filed 2019·Granted Jul 12, 2022·0 cites·4 claims
- 0260US2023323389A1Synthetic modified vaccinia ankara (smva) based coronavirus vaccinesHOPE CITY·Filed 2021·Application pending·0 cites
- 0359US2025235527A1Synthetic modified vaccinia ankara (smva) based coronavirus vaccinesHOPE CITY·Filed 2022·Application pending·0 cites
- 0458US2025009873A1Methods of preventing, treating, or reducing the severity of covid-19 in immunocompromised blood cancer patientsHOPE CITY·Filed 2022·Application pending·0 cites
- 0558US2025026794A1Methods of preventing, treating, or reducing the severity of coronavirus disease 2019 (covid-19)HOPE CITY·Filed 2022·Application pending·0 cites
- 0656US2023233666A1SYNTHETIC MODIFIED VACCINIA ANKARA (sMVA) BASED CORONAVIRUS VACCINESHOPE CITY·Filed 2022·Application pending·0 cites
- 0753US10487139B2MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereofHOPE CITY·Filed 2018·Granted Nov 26, 2019·0 cites·13 claims
- 0845US2024082403A1Chimeric Antigen Receptors against Human CytomegalovirusUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Flavia Chiuppesi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →